Post
Komoh
Moderna Q3 Outlook: Moderna (MRNA) is set to report its Q3 results before the US market open on Nov 6, following a net loss of approximately $800M in Q2.
Market Sentiment: Sentiment on the prediction market "Will Moderna (MRNA) beat quarterly earnings?" leans heavily optimistic, with 94% voting "Yes" against 6% for "No" on a volume of 2.61M.
#ModernaQ3VaccineSales
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Trending crypto
BTC/USDTBitcoin
$63,796-0.03%
ETH/USDTEthereum
$1,748.31-0.05%
SOL/USDTSolana
$69.28-0.06%
Today’s market buzz
1#WhoIsNextNvidiaCEO
2#USPPIBelowForecasts
3#AnthropicIPOOrderDemand